May 8, 2026, 5:57 PMglobenewswire.comLSBCF
LSBCF Investors Have Opportunity to Join LakeShore Biopharma Co., Ltd Fraud Investigation with the Schall Law Firm
Company announcementsLegal proceedings
LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LakeShore Biopharma Co., Ltd (“LakeShore Biopharma” or “the Company”) (OTC: LSBCF) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
